Bivalirudin

128270-60-0

CS-O-06181

C₉₈H₁₃₈N₂₄O₃₃

2180.32

O=C(N(CCC1)[C@@H]1C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@H](C(O)=O)CC(C)C)=O)CC2=CC=C(O)C=C2)=O)=O)=O)[C@@]([C@@H](C)CC)([H])NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@@H](NC([C@H](CC(O)=O)NC(CNC([C@H](CC(N)=O)NC(CNC(CNC(CNC(CNC([C@H](CCC3)N3C([C@H](CCCNC(N)=N)NC([C@H](CCC4)N4C([C@H](N)CC5=CC=CC=C5)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=O)=O

API

Bivalirudin

Store at refrigerator (2-8°C) for long term storage

(S)-4-((S)-2-((S)-2-(2-((S)-2-(2-(2-(2-(2-((S)-1- (D-Phenylalanyl-L-prolyl-L-arginyl)pyrrolidine-2-carboxamido)acetamido)acetamido)acetamido)acetami do)-4-amino-4-oxobutanamido)acetamido)-3-carboxypropanamido)-3-phenylpropanamido)-5- (((S)-4-carboxy-1-(((2S,3S)-1-((S)-2-(((S)-4-carboxy-1-(((S)-4-carboxy-1-(((S)-1- (((S)-1-carboxy-3-methylbutyl)amino)-3- (4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-1-oxobutan-2-yl)amino)-1-oxobutan-2-yl)carbamoyl)pyrrol idin-1-yl)-3-methyl-1-oxopentan-2-yl)amino)-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

"1, Seybert AL;coons c; Zerumsky K: Treatment of heparin-indced thrombcytopenia: is there a role for bivalirudin? Pharmcotherapy, 2006 Feb;26(2):229-41, Pubmed"

Not available

"For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes"

>98%

Refer MSDS for accurate information.